Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82,871 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: Satellites reveal hotspots of global river extent change.
Wu Q, Ke L, Wang J, Pavelsky TM, Allen GH, Sheng Y, Duan X, Zhu Y, Wu J, Wang L, Liu K, Chen T, Zhang W, Fan C, Yong B, Song C. Wu Q, et al. Among authors: zhang w. Nat Commun. 2023 May 5;14(1):2609. doi: 10.1038/s41467-023-38302-1. Nat Commun. 2023. PMID: 37147293 Free PMC article. No abstract available.
Satellites reveal hotspots of global river extent change.
Wu Q, Ke L, Wang J, Pavelsky TM, Allen GH, Sheng Y, Duan X, Zhu Y, Wu J, Wang L, Liu K, Chen T, Zhang W, Fan C, Yong B, Song C. Wu Q, et al. Among authors: zhang w. Nat Commun. 2023 Mar 22;14(1):1587. doi: 10.1038/s41467-023-37061-3. Nat Commun. 2023. PMID: 36949069 Free PMC article.
Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study.
Zhang B, Liu H, Shi C, Gao Z, Zhong R, Gu A, Chu T, Wang H, Xiong L, Zhang W, Zhang X, Yan B, Teng J, Wang W, Bai H, Qiao R, Cheng L, Kuang Y, Zhao R, Zhong H, Han B. Zhang B, et al. Among authors: zhang w. BMC Cancer. 2024 Jun 11;24(1):715. doi: 10.1186/s12885-024-12479-0. BMC Cancer. 2024. PMID: 38862908 Clinical Trial.
Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial.
Huang J, Wang Y, Xu F, Wang Z, Wu G, Kong W, Cheoklong NG, Tricard T, Wu X, Zhai W, Zhang W, Zhang J, Zhang D, Chen S, Lian Y, Chen Y, Zhang J, Huang Y, Xue W. Huang J, et al. Among authors: zhang w. J Immunother Cancer. 2024 Jun 11;12(6):e008475. doi: 10.1136/jitc-2023-008475. J Immunother Cancer. 2024. PMID: 38862251 Clinical Trial.
82,871 results
You have reached the last available page of results. Please see the User Guide for more information.